Global Health & Biotech Archives | Page 13 of 287 | Be Korea-savvy

Archive by category Global Health & Biotech

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

SHANGHAI, Sept. 07, 2025 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that company’s product, recombinant humanized anti-IL-17A monoclonal antibody (code: JS005) has achieved positive results in a multi-center, randomized, double-blind, parallel, placebo-controlled [...]

AAVantgarde presents updated positive clinical data from its AAVB-081 program for Usher 1B at EURetina 2025

AAVantgarde presents updated positive clinical data from its AAVB-081 program for Usher 1B at EURetina 2025

MILAN, Sept. 05, 2025 (Korea Bizwire) – AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated clinical data from the LUCE-1 study at the 25th European Society of Retina Specialists (EURETINA) Annual Congress (EURetina 2025), taking place in Paris 4-7 September 2025. Data presented by Prof. [...]

Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform

Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform

BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam Capital Upsized and over-subscribed Series A total funding of $44 million secured Rapafusyn’s RapaGlue™ platform rapidly discovers non-degrading molecular glues, a validated and highly sought-after modality to address challenging disease targets BALTIMORE, MD, Sept. [...]

Avania Strengthens Leadership Team with Appointment of Four New Executives

Avania Strengthens Leadership Team with Appointment of Four New Executives

BILTHOVEN, Netherlands and BOSTON, Sept. 04, 2025 (Korea Bizwire) – Avania, the leading global MedTech advisory and clinical development partner, is pleased to announce strategic leadership appointments of four distinguished executives. As the MedTech industry navigates increasing regulatory complexity and technological innovation, these new leaders bring decades of combined experience in clinical research, regulatory affairs, operations, [...]

PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen

PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen

New Preprint: PridCor Therapeutics LLC has released a pre-print detailing a case series of 15 patients with Long COVID (LC) who were given a continuous regimen of 120-days of valacyclovir and celecoxib with a pulsed 15-day treatment of Paxlovid (combination antiviral treatment, or CAR), and these patients were compared to 12 patients with Long COVID who [...]

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health care SAN DIEGO, Sept. 03, 2025 (Korea Bizwire) – Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the launch of Sleep Institute, a global [...]

EVIDENT and Siemens Healthineers Join Efforts to Advance Digital Pathology at Klinikum Ludwigshafen

EVIDENT and Siemens Healthineers Join Efforts to Advance Digital Pathology at Klinikum Ludwigshafen

Collaboration combines AI imaging, diagnostics expertise, and clinical leadership to drive digital pathology forward WALTHAM, Mass. and ERLANGEN, Germany and LUDWIGSHAFEN, Germany, Sept. 03, 2025 (Korea Bizwire) – Siemens Healthineers, a leading global medical technology company, and Evident — which recently acquired Pramana, an AI-enabled health tech company modernizing the pathology sector — announced a [...]

BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures

BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures

BVI announces Virtuoso®, its first dual-function phaco-vitrectomy system designed to deliver advanced control, efficiency, and versatility for both cataract and vitreoretinal surgery. European debut planned for 2025 Global ophthalmic congresses in Europe (Euretina and ESCRS). WALTHAM, Mass., Sept. 03, 2025 (Korea Bizwire) – BVI, a leading global ophthalmic device company dedicated to sitting at the [...]

Persephoni Launches Strategic Sponsorship with American Cancer Society’s BrightEdge to Accelerate Oncology Innovation

Persephoni Launches Strategic Sponsorship with American Cancer Society’s BrightEdge to Accelerate Oncology Innovation

RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (Korea Bizwire) — Persephoni BioSciences LLC (“Persephoni”), a leading global life sciences venture studio, is proud to announce a $1.5 million sponsorship to American Cancer Society BrightEdge LLC (“BrightEdge”) in support of its innovation acceleration programs. As a leading sponsor, Persephoni and BrightEdge will also develop a strategic [...]

WeightWatchers Advances International Growth With Strategic Leadership Appointment

WeightWatchers Advances International Growth With Strategic Leadership Appointment

Alejandro Bethlen to Lead WeightWatchers’ Next Phase of International Growth and Innovation, Building on More Than 50 Years in Global Markets NEW YORK, Sept. 03, 2025 (Korea Bizwire) — WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced the appointment of Alejandro Bethlen as Executive Vice [...]